Cleary S - Search Results

1

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R. Badri M, et al. Among authors: cleary s. Antivir Ther. 2006;11(1):63-72. Antivir Ther. 2006. PMID: 16518961

2

The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.

Cleary SM, McIntyre D, Boulle AM. Cleary SM, et al. Cost Eff Resour Alloc. 2006 Dec 6;4:20. doi: 10.1186/1478-7547-4-20. Cost Eff Resour Alloc. 2006. PMID: 17147833 Free PMC article.

3

When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.

Loubiere S, el Filal KM, Sodqi M, Loundou A, Luchini S, Cleary S, Moatti JP, Himmich H. Loubiere S, et al. Among authors: cleary s. Antivir Ther. 2008;13(2):241-51. Antivir Ther. 2008. PMID: 18505175

4

Assessing efficiency and costs of scaling up HIV treatment.

Cleary SM, McIntyre D, Boulle AM. Cleary SM, et al. AIDS. 2008 Jul;22 Suppl 1:S35-42. doi: 10.1097/01.aids.0000327621.24232.71. AIDS. 2008. PMID: 18664951

5

Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital).

Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S. Kevany S, et al. Among authors: cleary s. S Afr Med J. 2009 May;99(5):320-5. S Afr Med J. 2009. PMID: 19588792

6

The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.

Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J. Sinanovic E, et al. Among authors: cleary s. Vaccine. 2009 Oct 19;27(44):6196-202. doi: 10.1016/j.vaccine.2009.08.004. Epub 2009 Aug 19. Vaccine. 2009. PMID: 19698807

7

Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting.

Cleary S, Mooney G, McIntyre D. Cleary S, et al. Health Econ. 2010 Oct;19(10):1166-80. doi: 10.1002/hec.1542. Health Econ. 2010. PMID: 19725025

8

Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.

Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, Little F, Maartens G. Leisegang R, et al. Among authors: cleary s. PLoS Med. 2009 Dec;6(12):e1000189. doi: 10.1371/journal.pmed.1000189. Epub 2009 Dec 1. PLoS Med. 2009. PMID: 19956658 Free PMC article.

9

Early severe morbidity and resource utilization in South African adults on antiretroviral therapy.

de Cherif TK, Schoeman JH, Cleary S, Meintjes GA, Rebe K, Maartens G. de Cherif TK, et al. Among authors: cleary s. BMC Infect Dis. 2009 Dec 15;9:205. doi: 10.1186/1471-2334-9-205. BMC Infect Dis. 2009. PMID: 20003472 Free PMC article.

10

Association of antiretroviral therapy adherence and health care costs.

Nachega JB, Leisegang R, Bishai D, Nguyen H, Hislop M, Cleary S, Regensberg L, Maartens G. Nachega JB, et al. Among authors: cleary s. Ann Intern Med. 2010 Jan 5;152(1):18-25. doi: 10.7326/0003-4819-152-1-201001050-00006. Ann Intern Med. 2010. PMID: 20048268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters